Loading…

Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality

The syndrome of combined pulmonary fibrosis and emphysema (CPFE) primarily due to tobacco smoking has been reported in connective tissue disease, but little is known about its characteristics in systemic sclerosis (SSc). In this retrospective multi-center case-control study, we identified 36 SSc pat...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in arthritis and rheumatism 2019-08, Vol.49 (1), p.98-104
Main Authors: Champtiaux, N., Cottin, V., Chassagnon, G., Chaigne, B., Valeyre, D., Nunes, H., Hachulla, E., Launay, D., Crestani, B., Cazalets, C., Jego, P., Bussone, G., Bérezné, A., Guillevin, L., Revel, M.P., Cordier, J.F., Mouthon, L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The syndrome of combined pulmonary fibrosis and emphysema (CPFE) primarily due to tobacco smoking has been reported in connective tissue disease, but little is known about its characteristics in systemic sclerosis (SSc). In this retrospective multi-center case-control study, we identified 36 SSc patients with CPFE, and compared them with 72 SSc controls with interstitial lung disease (ILD) without emphysema. Rate of CPFE in SSc patients with CT scan was 3.6%, and 7.6% among SSc patients with ILD. CPFE-SSc patients were more likely to be male (75 % vs 18%, p 
ISSN:0049-0172
1532-866X
DOI:10.1016/j.semarthrit.2018.10.011